http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
허승재 대한방사선종양학회 2008 Radiation Oncology Journal Vol.26 No.1
저자는 최근 한중일 심포지엄(Tri-lateral Symposium on Radiation Oncology China Japan Korea Nov 14, 2007 Beijing, China)과 제 20회 일본방사선종양학회에 참석하여(JASTRO Dec. 13∼15, 2007, Fukuoka, Japan) 수집한 정보를 통하여 최근 일본과 중국의 방사선치료 분야의 현황과 동향을 분석, 보고하려 한다.
자궁 경부암 고선량율 강내조사 치료의 국내 현황과 적정 치료방법
허승재,Huh, Seung-Jae 대한방사선종양학회 1998 Radiation Oncology Journal Vol.16 No.4
Brachytherapy is an essential part of radiotherapy for uterine cervical cancer. The low dose rate (LDR) regimen has been the major technique of intracavitary therapy for cervical cancer. However, there has been an expansion in the last 20 years of high dose rate (HDR) machines using Ir-192 sources. Since 1979, HDR brachytherapy has been used for the treatment of uterine cervical cancer in Korea. The number of institutions employing HDR has been increasing, while the number of low dose rate system has been constant. In 1995, there was a total 27 HDR brachytherapy units installed and 1258 cases of patients with cervical cancer were treated with HDR Most common regimens of HDR brachytherapy are total dose of 30-39 Gy at point A with 10-13 fractions in three fractions per week. 24-32 Gy with 6-8 fractions in two fractions per week, and 30-35 Gy with 6-7 fractions in two fractions per week. The average fractionation regimen of HDR brachytherapy is about 8 fractions of 4.1 Gy each to Point A. In Korea, treatment results for HDR brachytherapy are comparable with the LDR series and appears to be a safe and effective alternative to LDR therapy for the treatment of cervical carcinoma. Studies from the major centers report the five-year survival rate of cervical cancer as. 78-86$\%$ for Stage 1, 68-85$\%$ for stage 11, and 38-56$\%$ for Stage III. World-wide questionnaire study and Japanese questionnaire survey of multiple institutions showed no survival difference in any stages and dose-rate effect ratio (HDR/LDR) was calculated to be 0.54 to 0.58. However the optimum treatment doses and fractionation schemes appropriate to generate clinical results comparable to conventional LDR schemes have yet to be standardized. In conclusion, HDR intracavitary radiotherapy is increasingly practiced in Korea and an effective treatment modality for cervical cancer. To determine the optimum radiotherapy dose and fractionation schedule, a nation-wide prospective study is necessary in Korea. In addition, standardization of HDR application (clinical, computer algorithms, and dosimetric aspects) is necessary.
허승재,우홍균,안용찬,김대용,신경환,이규찬,정원아,김현주,Huh Seung Jae,Wu Hong Gyun,Ahn Yong Chan,Kim Dae Yong,Shin Kyung Hwan,Lee Kyu Chan,Chong Won A,Kim Hyun Joo The Korean Society for Radiation Oncology 1998 Radiation Oncology Journal Vol.16 No.3
목적 : 본 연구는 계획된 방사선치료의 과정 도중에 방사선치료를 완료하지 못하는 환자들의 빈도를 조사하고 그 이유를 분석하고자 하였다. 대상 및 방법 :삼성서울병원 치료방사선과에서 방사선치료를 받은 환자 중에서 1996년 4월부터 1997년 5월까지 방사선치료를 시행 받은 1,100명의 환자들을 대상으로 하였다. 대상 환자들 중에서 최초 계획 방사선량의 95$\%$ 이하를 받은 경우를 불완전 방사선치료로 정의하여 그 빈도와 이유를 조사하였다. 결과 : 불완전 방사선치료의 빈도는 1,100명 중 128명으로 12$\%$였다. 불완전 방사선치료 환자들의 운동수행능력은 전체 환자들에 비하여 불량하였으며, 방사선치료의 목적은 고식적 목적이 많았다. 불완전 방사선치료의 가장 흔한 이유는 환자의 거부였으며 이는 주로 환자의 방사선치료에 대한 불신과 경제적 부담 때문이었다. 결론 : 불완전 방사선치료의 빈도를 줄이기 위해서는 방사선치료의 임상적 적응 여부는 물론 환자의 사회 경제적인 여건을 잘 고려하여 방사선치료의 대상 환자를 선정하는 것이 요망되며 이는 특히 고식적 방사선치료의 경우에 더욱 중요하다고 할 수 있겠다. Purpose : This study is to see how much proportion of the patients receiving radiation therapy drop out during radiation therapy and to analyze the reason for the incomplete treatment. Materials and Methods : The base population of this study was 1,100 patients with registration numbers 901 through 2,000 at Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea. Authors investigated the incidence of incomplete radiation therapy, which was defined as less than 95$\%$ of initially planned radiation dose, and the reasons for incomplete radiation therapy. Results : One hundred and twenty eight patients (12$\%$) did not complete the planned radiation therapy. The performance status of the incompletely treated patients was generally Poorer than that of the base population, and the aim of radiation therapy was more commonly palliative. The most common reason for not completing the planned treatment was the patients' refusal of further radiation therapy because of the distrust of radiation therapy and/or the poor economic status. Conclusion : Careful case selection for radiation therapy with consideration of the socioeconomic status of the patients in addition to the clinical indication would be necessary for the reduction of incomplete treatment, especially in the palliative setting.
허승재 순천향대학교 1993 논문집 Vol.16 No.4
From July 1985 to April 1993, total 2040 new patients with malignant neoplasms were treated by radiation in the Department of Therapeutic Radiology, Soonchunhyang University Hospital. Male cases were 872, and female were 1168. Curative radiotherapy was done in 830 (41%) patients, palliative in 563 (28%), and pre or post-op radiotherapy in 503(25%). Most common tumors were lung cancer in male, and uterine cervical cancer in femalw. Some clinical features of the malignant neoplasms treated by radiotherapy were discussed.
허승재,하성환,채규영,Huh, Seung-Jae,Ha, Sung-Whan,Chai, Kyu-Young The Korean Society for Radiation Oncology 1987 Radiation Oncology Journal Vol.5 No.2
자궁경부암의 고선량율 강내치료의 매 분할 치료시마다 강내 applicator의 위치 차이로 인하여 조사 선량이 치료전 계획된 선량과 차이가 있을 수 있다. 저자는 자궁경부암 환자의 강내치료시 치료전 계획된 A점 선량 500 cGy와 치료직후에 촬영한 전후 및 측면 선 사진을 이용하여 계산된 A점 선량을 비교한 결과, 82예의 강내치료에서 치료 후 계산된 조사 선량과 계획 선량은 $500\pm18 cGy$이었으며 $84\%$에서 $500\pm25 cGy$의 범위에 포함되었다. 이러한 결과에서 계획 선량과 치료 후 계산된 조사 선량사이에 비교적 높은 일치율을 확인할 수 있었다. In brachytherapy of uterine conical cancer using a high dose rate remote afterloading system, it is of prime importance to deliver a accurate dose in each fractionated treatment by minimizing the difference between the pre-treatment planned and post-treatment calculated doses. The post-treatment calculated point A dose was not much different from the pretreatment planned dose (500 cGy). The $average{\pm}standard$ deviation was $500\pm18cGy$ and 84 percent of 82 intracavitary radiotherapy was within the range of $500\pm25cGy$.